Sri Lanka

Resilience System


You are here

Science

Coronavirus Reinfections Are Real but Very, Very Rare

 

Reports of reinfection with the coronavirus evoke a nightmarish future: Repeat bouts of illness, impotent vaccines, unrelenting lockdowns — a pandemic without an end.

A case study published Monday, about a 25-year-old man in Nevada, has stoked those fears anew. The man, who was not named, became sicker the second time that he was infected with the virus, a pattern the immune system is supposed to prevent.

But these cases make the news precisely because they are rare, experts said: More than 38 million people worldwide have been infected with the coronavirus, and as of Monday, fewer than five of those cases have been confirmed by scientists to be reinfections.

“That’s tiny — it’s like a microliter-sized drop in the bucket, compared to the number of cases that have happened all over the world,” said Angela Rasmussen, a virologist at Columbia University in New York.

In most cases, a second bout with the virus produced milder symptoms or none at all. But for at least three people, including one patient in Ecuador, the illness was more severe the second time around than during the first infection. An 89-year-old woman in the Netherlands died during her second illness.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Regeneron CEO: Trump ‘is a case of one’ and ‘weakest evidence’ for Covid-19 treatment

Regeneron chief executive Leonard Schleifer on Sunday said President Donald Trump's treatment with the company's experimental antibody cocktail is "a case of one," but stressed ongoing clinical trials still need to show its efficacy.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Antibody drugs are no cure but seem promising for COVID-19

WASHINGTON (AP) — They’re not cures and it’s not likely that everyone will be able to get them as President Donald Trump has suggested. But experimental antibody drugs like the one Trump was given are among the most promising therapies being tested for treating and preventing coronavirus infections.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Lilly seeks emergency use of its antibody drug for COVID-19

A drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

White House Blocks New Coronavirus Vaccine Guidelines

WASHINGTON — Top White House officials are blocking strict new federal guidelines for the emergency release of a coronavirus vaccine, objecting to a provision that would almost certainly guarantee that no vaccine could be authorized before the election on Nov. 3, according to people familiar with the approval process.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Science
howdy folks